Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Lee

Showing results (321-330 of 628) with videos related to

Pageof 63
Sort By:
Carcinogenesis|July 15, 2010
Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinomaJianming Wang, Scott M Lippman, J Jack Lee, et al.
Glycobiology|July 9, 2015
Cell surface glycan engineering of neural stem cells augments neurotropism and improves recovery in a murine model of multiple sclerosisJasmeen S Merzaban, Jaime Imitola, Sarah C Starossom, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2017
Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled TrialsJennifer K Logan, Chad Tang, Zhongxing Liao, et al.
Annals of the New York Academy of Sciences|November 30, 2006
Three-dimensional models of individual cardiac histoanatomy: tools and challengesRebecca A B Burton, Gernot Plank, Jürgen E Schneider, et al.
Oncogene|November 22, 2002
Differential expression profiling of head and neck squamous carcinoma: significance in their phenotypic and biological classificationAdel K El-Naggar, Hyung W Kim, Gary L Clayman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2012
Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemopreventionMichelle A T Hildebrandt, Scott M Lippman, Carol J Etzel, et al.
JCO Precision Oncology|September 11, 2020
Use of a Targeted Exome Next-Generation Sequencing Panel Offers Therapeutic Opportunity and Clinical Benefit in a Subset of Patients With Advanced CancersScott Kopetz, Kenna R Mills Shaw, J Jack Lee, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 5, 2011
Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patientsJ Jack Lee, Xifeng Wu, Michelle A T Hildebrandt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2010
A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosisHumam Kadara, Carmen Behrens, Ping Yuan, et al.
Journal of the National Cancer Institute|November 15, 2007
Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor geneQingguo Tao, Junya Fujimoto, Taoyan Men, et al.
Pageof 63

Showing results (321-330 of 628) with videos related to

Sort By:
Pageof 63
Carcinogenesis|July 15, 2010
Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinomaJianming Wang, Scott M Lippman, J Jack Lee, et al.
Glycobiology|July 9, 2015
Cell surface glycan engineering of neural stem cells augments neurotropism and improves recovery in a murine model of multiple sclerosisJasmeen S Merzaban, Jaime Imitola, Sarah C Starossom, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2017
Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled TrialsJennifer K Logan, Chad Tang, Zhongxing Liao, et al.
Annals of the New York Academy of Sciences|November 30, 2006
Three-dimensional models of individual cardiac histoanatomy: tools and challengesRebecca A B Burton, Gernot Plank, Jürgen E Schneider, et al.
Oncogene|November 22, 2002
Differential expression profiling of head and neck squamous carcinoma: significance in their phenotypic and biological classificationAdel K El-Naggar, Hyung W Kim, Gary L Clayman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2012
Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemopreventionMichelle A T Hildebrandt, Scott M Lippman, Carol J Etzel, et al.
JCO Precision Oncology|September 11, 2020
Use of a Targeted Exome Next-Generation Sequencing Panel Offers Therapeutic Opportunity and Clinical Benefit in a Subset of Patients With Advanced CancersScott Kopetz, Kenna R Mills Shaw, J Jack Lee, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 5, 2011
Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patientsJ Jack Lee, Xifeng Wu, Michelle A T Hildebrandt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2010
A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosisHumam Kadara, Carmen Behrens, Ping Yuan, et al.
Journal of the National Cancer Institute|November 15, 2007
Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor geneQingguo Tao, Junya Fujimoto, Taoyan Men, et al.
Pageof 63